Intuit Other Non-Current Liabilities increased by 9.8% to $358.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 21.8%, from $294.00M to $358.00M. Over 5 years (FY 2020 to FY 2025), Other Non-Current Liabilities shows an upward trend with a 49.0% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate rising long-term operational risks or deferred tax burdens, while a decrease suggests the settlement of these obligations.
This represents miscellaneous long-term obligations that do not fit into standard categories like long-term debt or pens...
Peers in the medical device and pharmaceutical sectors often hold similar balances related to deferred tax liabilities and long-term environmental or legal accruals.
other_non_current_liabilities| Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $56.00M | $53.00M | $51.00M | $73.00M | $86.00M | $87.00M | $89.00M | $88.00M | $116.00M | $121.00M | $144.00M | $138.00M | $217.00M | $208.00M | $221.00M | $221.00M | $294.00M | $308.00M | $316.00M | $326.00M | $358.00M |
| QoQ Change | — | -5.4% | -3.8% | +43.1% | +17.8% | +1.2% | +2.3% | -1.1% | +31.8% | +4.3% | +19.0% | -4.2% | +57.2% | -4.1% | +6.3% | +0.0% | +33.0% | +4.8% | +2.6% | +3.2% | +9.8% |
| YoY Change | — | — | — | — | +53.6% | +64.2% | +74.5% | +20.5% | +34.9% | +39.1% | +61.8% | +56.8% | +87.1% | +71.9% | +53.5% | +60.1% | +35.5% | +48.1% | +43.0% | +47.5% | +21.8% |